USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ACTUATED MEDICAL, INC.
Address:
310 ROLLING RIDGE DR
Bellefonte, PA 16823-8445
Phone:
(814) 355-0003
URL:
N/A
EIN:
120811128
DUNS:
791379030
Number of Employees:
20
Woman-Owned?:
Yes
Minority-Owned?:
No
HUBZone-Owned?:
No

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,992,092.00 12
SBIR Phase II $10,499,785.00 8

Award List:

SBIR Phase I: Active Device for Reliable Cleaning of Feeding Tubes

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research Phase I project will develop the Tube-Clear device to remove clots from feeding tubes. In excess of 411,000 people receive feeding tubes annually in the United States. Feeding tubes become a requirement when critically ill and compromised patients lose the… More

LIFE, Low Insertion Force Epidural to Reduce Insertion Force

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This Phase I NIH SBIR, will design and demonstrate the Low Insertion Force Epidural (LIFE) insertion tool. Epidural anesthesia is a form of regional anesthesia involving injection of drugs directly into the epidural spa ce and is used in 2.4 million births every… More

SBIR Phase II: Active Device for Reliable Cleaning of Feeding Tubes

Award Year / Program / Phase:
2009 / SBIR / Phase II
Award Amount:
$500,000.00
Agency:
NSF
Principal Investigator:
Abstract:
This award is funded under the American Recovery and Reinvestment Act of 2009 (Public Law 111-5). This Small Business Innovation Research Phase II project will continue development of the Tube-Clear(TM) device to clear clogged and sluggish feeding tubes, satisfying a critical medical need and… More

Lightweight Electronically Controlled Transdermal Patch for Enfuvirtide Delivery

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$99,997.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This Phase I NIH SBIR, will develop a Lightweight Electronically Controlled Transdermal Patch for Enfuvirtide Delivery (LET-PED). Thirty-three million people worldwide are living with the Human Immunodeficiency Virus (H IV). Currently, patients infected with HIV… More

Resonance Driven Vascular Entry Needle to Reduce Insertion Forces

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$123,344.00
Agency:
HHS
Principal Investigator:
Debora L. Demers
Abstract:
DESCRIPTION (provided by applicant): In this Phase I NIH SBIR, Piezo Resonance Innovations will demonstrate feasibility of the Resonance Driven Vascular Entry Needle (RVEN), a device that facilitates successful venipuncture, particularly of veins that are difficult and problematic to access due to… More

Biopsy Reduction of Force Tool for Improved Sample Collection and Minimize Patien

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$180,356.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): In this Phase I NIH SBIR program, PRII will develop the Biopsy Force Reduction (BIFOR) Tool for adult patient Bone Marrow Biopsy. The BIFOR will reduce insertion force, improve biopsy sample quality and sampling rate s uccess, and decrease patient discomfort and… More

Low Insertion Force Epidural, LIFE System for Controlled Insertion

Award Year / Program / Phase:
2010 / SBIR / Phase II
Award Amount:
$976,545.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant: In this Phase II NIH SBIR, the Low Insertion Force Epidural (LIFE) device will be further optimized and efficacy measured on human cadavers and live porcine models. Piezo Resonance Innovations, Inc. successfully designed and demonstrated the Phase I LIFE device… More

Resonance Aided Insertion Lancet for serial blood sampling in age-related studies

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$156,655.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Rodent studies have provided significant insights into the general aging process and age-related topics such as nutrition, behavior, immunology, cancer, and neurobiology. In such studies, concentrations of hormones, pro teins, antibodies, and other metabolites… More

Pediatric Gastrojejunal Feeding Tube (GJ-tube) Cleaner

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$290,119.00
Agency:
HHS
Principal Investigator:
Ryan S. Clement – (814) 355-0003
Abstract:
DESCRIPTION (provided by applicant): Long-term enteral nutrition, via a feeding tube, is often provided to pediatric patients who have a functioning gastrointestinal tract but are at risk of malnutrition due to their inability to properly ingest nutrientsorally. Enteral feeding can be accomplished… More

RAIL reduces variability and concentration of stress hormones in blood sampling

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$1,448,168.00
Agency:
HHS
Principal Investigator:
Ryan S. Clement – (814) 355-0003
Abstract:
DESCRIPTION (provided by applicant): In this Phase II SBIR, Actuated Medical, Inc. (f/k/a Piezo Resonance Innovations, Inc) will complete the development of the Resonance Assisted Insertion Lancet (RAIL ) System to reduce animal pain and stress response during laboratory animal blood sampling.… More

Portable electronically controlled transdermal patch for enfuvirtide delivery

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$1,957,909.00
Agency:
HHS
Principal Investigator:
Maureen L. Mulvihill – (814) 355-0003
Abstract:
DESCRIPTION (provided by applicant): In this Phase II NIH SBIR, Piezo Resonance Innovations will further optimize and test the Portable Transdermal Patch (PTP) - a needle-free platform delivery technology for drugs and vaccines that are currently deliveredsubcutaneously. The portable, 200gm (7oz)… More

Actuated Fine-Gauge Spinal Needle Insertion to Reduce Dura Damage and PDPH Risk

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$253,861.00
Agency:
HHS
Principal Investigator:
Maureen L. Mulvihill – (814) 355-0003
Abstract:
DESCRIPTION (provided by applicant): In this NIH SBIR program, Actuated Medical, Inc. (AMI), (formerly Piezo Resonance Innovations, Inc) will develop and test the Actuated Spinal Anesthesia (SIS or 'Smooth Insertion Spinal') Needle Insertion Tool to ReduceDural Damage and Post Dural… More

Temperature-Tolerant COLD-PCR enables mutation-enriched targeted re-sequencing

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$212,770.00
Agency:
HHS
Principal Investigator:
Roger B. Bagwell – (814) 355-0003
Abstract:
DESCRIPTION (provided by applicant): This Phase I SBIR develops and tests the active Pedi ET-Clear system to clean mucus from 2.5 mm diameter neonatal endotracheal tubes with significantly reduced deleterious impact on lung function and mechanics, as compared to current methods. Actuated Medical,… More

Actuated Low-Force Biopsy Tool for Versatile Bone Lesion Access with Less Trauma

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$1,714,815.00
Agency:
HHS
Principal Investigator:
Maureen L. Mulvihill – (814) 355-0003
Abstract:
DESCRIPTION (provided by applicant): In this Phase II SBIR, Actuated Medical, Inc. will complete the development of the Actuated Low-Force Biopsy Tool for Versatile Bone Lesion Access with Less Trauma. Public Health Problem: Percutaneous bone biopsy is performed to obtain tissue for specific… More

In-Patient Pediatric Gastrojejunal Tube Cleaner Eliminating Surgical Intervention

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$1,683,578.00
Agency:
HHS
Principal Investigator:
Ryan S. Clement – (814) 355-0003
Abstract:
DESCRIPTION (provided by applicant): In this Phase II NIH SBIR, Actuated Medical, Inc. will complete the development of the Pedi-GJ-ClearTM device for clearing occlusions and restoring patency in-situ to pediatric gastrojejunal feeding tubes (GJ-tubes) - eliminating the need to surgically replace… More

Active Needle Technology for Cattle to Reduce Insertion Force, Pain and Meat Loss from Injection Scarring while Facilitating Vascular Access

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
USDA
Principal Investigator:
Maureen L. Mulvihill, President&CEO – (814) 355-0003
Abstract:
This project develops the "Active Needle Technology System (ANTS) for Cattle to Reduce Insertion Force, Reduce Pain, Facilitate Vascular Access, and Reduce Meat Loss from Injection Scarring". This project meets Strategic Goal 3: Help America Promote Agricultural Production And… More

SBIR Phase I: Grip-Act-Reposition Miniaturized Stable Working Platform for Minimally Invasive Procedures Inside Active Organs

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$150,000.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research Phase I project will develop the ?Grip-Act-Reposition (GAR) Miniaturized Stable Working Platform for Minimally Invasive Procedures Inside Active Organs.? Working within or on moving organs ? like the heart or lungs ? is extremely challenging during minimally… More

SBIR Phase II: Grip-Act-Reposition Miniaturized Stable Working Platform for Minimally Invasive Procedures Inside Active Organs

Award Year / Program / Phase:
2014 / SBIR / Phase II
Award Amount:
$737,772.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research (SBIR) Phase II project will finalize the Grip-Act-Reposition (GAR) Miniaturized Stable Working Platform for Minimally Invasive Procedures Inside Active Organs - with initial focus on treating Atrial Fibrillation (AF). A common procedure for treating AF is… More

IGF::OT::IGF SBIR PHASE I TOPIC 331: PHOTOACOUSTIC NEEDLE FOR IDENTIFYING TUMOR CONTENT

Award Year / Program / Phase:
2014 / SBIR / Phase I
Award Amount:
$224,990.00
Agency:
HHS
Principal Investigator:
Kevin Snook – 814-355-0003
Abstract:
Not Available

Active Fine Gauge Spinal Needle with CSF Sensing to Minimize PDPH and Dura Damage

Award Year / Program / Phase:
2014 / SBIR / Phase II
Award Amount:
$1,480,998.00
Agency:
HHS
Principal Investigator:
Maureen L. Mulvihill – 814-355-0003
Abstract:
DESCRIPTION (provided by applicant): In this NIH SBIR Phase II, Actuated Medical, Inc. will finalize and clinically test the Active Fine Gauge Spinal Needle with CSF Sensing to Minimize PDPH and Dura Damage. Phase I achieved all Specific Aims and demonstrated that the Smooth Insertion Spinal (SIS)… More